Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Corcept Therapeutics Inc (NASDAQ:CORT)

12.09
Delayed Data
As of Jun 22
 +0.02 / +0.17%
Today’s Change
4.95
Today|||52-Week Range
12.57
+66.53%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues10.4M26.6M50.3M81.3M
 
 
 
 
 
Cost of Goods Sold69.0K741.0K1.2M2.0M
 
 
 
 
 
Depreciation And Amortization74.0K141.0K155.0K87.0K
 
 
 
 
 
 
Operating ExpensesGross Income10.2M25.7M48.9M79.3M
 
 
 
 
 
General Expenses51.7M53.3M52.4M69.1M
 
 
 
 
 
Research And Development20.5M18.4M15.4M23.8M
 
 
 
 
 
Total Operating Expenses51.9M54.2M53.7M71.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-41.5M-27.6M-3.4M10.2M
 
 
 
 
 
Interest Expense On Debt4.4M3.7M2.8M1.9M
 
 
 
 
 
Other Expenses-115.0K-64.0K-165.0K-110.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-46.0M-31.4M-6.4M8.1M
 
 
 
 
 
Net Income-46.0M-31.4M-6.4M8.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS99.8M101.0M106.9M110.6M
 
 
 
 
 
Shares To Calculate EPS Diluted99.8M101.0M106.9M110.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.46-$0.31-$0.06$0.07
 
 
 
 
 
EPS Diluted-$0.46-$0.31-$0.06$0.07